Jacob Plieth Profile picture
Journalist covering biopharma at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.
Sep 23, 2024 4 tweets 2 min read
So $BDTX going in hard on PACC mutations in EGFR+ resistant NSCLC. Here's what $AVBP had to say about PACC at #WCLC24, via @ByMadeleineA oncologypipeline.com/apexonco/world… $BDTX BDTX-1535 Image
Sep 28, 2019 6 tweets 3 min read
AMG 510 via discussant T Arkenau #ESMO19 $AMGN $MRTX Reminder of AMG 510 in NSCLC via T Arkenau #ESMO19 $AMGN $MRTX